BioCentury
ARTICLE | Clinical News

AutoloGel System regulatory update

May 21, 2012 7:00 AM UTC

The Centers for Medicare & Medicaid Services (CMS) issued a proposed decision memo supporting coverage of autologous platelet-rich plasma (PRP) gel under its coverage with evidence development (CED) mechanism to treat chronic, non-healing diabetic, venous and/or pressure wounds. CMS is expected to publish a final decision memo by August. CED is a mechanism for CMS to grant conditional coverage contingent on some form of clinical data collection. ...